Omeprazol MK

Omeprazol MK may be available in the countries listed below.

Ingredient matches for Omeprazol MK

Omeprazole

Omeprazole is reported as an ingredient of Omeprazol MK in the following countries:

• Colombia


• Ecuador

International Drug Name Search

Indobufen

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AC10

CAS registry number (Chemical Abstracts Service)

0063610-08-2

Chemical Formula

C18-H17-N-O3

Molecular Weight

295

Therapeutic Category

Antiplatelet agent, reversible cyclooxygenase inhibitor

Chemical Name

Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-α-ethyl-, (±)-

Foreign Names

• Indobufenum (Latin)
• Indobufen (German)
• Indobufène (French)
• Indobufen (Spanish)

Generic Names

• Indobufene (OS: DCIT)
• K 3920 (IS)

Brand Names

• Ibustrin
  Pfizer, Czech Republic; Pfizer, Italy; Pfizer, Poland; Pfizer, Portugal; Pfizer, Slovakia; Pfizer, Venezuela



• Indobufene Almus
  Almus, Italy



• Indobufene EG
  EG, Italy



• Indobufene Germed
  Germed Pliva, Italy



• Indobufene Mylan
  Mylan, Italy



• Indobufene Ranbaxy
  Ranbaxy, Italy



• Trisagon
  Finmedical, Italy

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ridaura

Pronunciation: or-RAIN-oh-fin
Generic Name: Auranofin
Brand Name: Ridaura

Ridaura contains gold, which can build up in the blood and become toxic. Report any symptom suggesting toxicity (rash, mouth sores, persistent diarrhea, indigestion, metallic taste, unusual bleeding or bruising, itching, blood in the urine, fainting) to your health care provider immediately.

Ridaura is used for:

Managing rheumatoid arthritis in patients who do not respond to or are intolerant of other medicines.

Ridaura is an antirheumatic agent. The way Ridaura works is not fully understood.

Do NOT use Ridaura if:

• you are allergic to any ingredient in Ridaura


• you have a history of blood and bone marrow disorders or disease


• you have inflammation and peeling of the skin, scar tissue on the lungs, or serious bowel inflammation


• you are taking penicillamine

Contact your doctor or health care provider right away if any of these apply to you.

Before using Ridaura:

Some medical conditions may interact with Ridaura. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have small red spots under the skin, unusual bleeding or bruising, eczema, liver disease, kidney problems, lupus, yellowing of the skin or eyes, inflammation of the skin or mouth, blood circulation problems, chronic arthritis accompanied by dry mouth/eyes, itching, skin rash, or colitis


• if you are receiving radiation therapy or are debilitated

Some MEDICINES MAY INTERACT with Ridaura. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Penicillamine because the risk of serious blood or kidney problems may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Ridaura may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Ridaura:

Use Ridaura as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Ridaura may be taken with or without food.


• Ridaura comes with an additional patient leaflet. Read it carefully and reread it each time you get Ridaura refilled.


• If you miss a dose of Ridaura, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Ridaura.

Important safety information:

• Three to six months may pass before you feel the full effect of Ridaura. Do not stop taking Ridaura without checking with your doctor.


• Ridaura may cause increased sensitivity to the sun. Avoid exposure to the sun, sunlamps, or tanning booths until you know how you react to Ridaura. Use a sunscreen or wear protective clothing if you must be outside for a prolonged period.


• LAB TESTS, including complete blood cell counts, may be performed to monitor your progress. Be sure to keep all doctor and lab appointments.


• Ridaura is not recommended for use in CHILDREN. Safety and effectiveness have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Ridaura during pregnancy. It is unknown if Ridaura is excreted in breast milk. Do not breast-feed while taking Ridaura.

Possible side effects of Ridaura:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Abdominal pain; constipation; diarrhea; gas; inflammation of the eye, mouth, or skin; itching; loose stools; nausea; stomach pain; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bleeding disorder; blood in the urine; fainting; indigestion; itching; metallic taste; mouth sores; peeling skin; persistent diarrhea; purple blotches or other unusual skin spots; rash; shortness of breath; sore throat; unusual bleeding or bruising; unusual weakness.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Ridaura side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include diarrhea; fever; nausea; skin disorders (hives and severe itching); vomiting.

Proper storage of Ridaura:

Store Ridaura at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly closed container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Ridaura out of the reach of children and away from pets.

General information:

• If you have any questions about Ridaura, please talk with your doctor, pharmacist, or other health care provider.


• Ridaura is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Ridaura. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Ridaura resources

• Ridaura Side Effects (in more detail)
• Ridaura Use in Pregnancy & Breastfeeding
• Drug Images
• Ridaura Drug Interactions
• Ridaura Support Group
• 2 Reviews for Ridaura - Add your own review/rating

• Ridaura Prescribing Information (FDA)


• Ridaura Concise Consumer Information (Cerner Multum)


• Ridaura Advanced Consumer (Micromedex) - Includes Dosage Information


• Auranofin Professional Patient Advice (Wolters Kluwer)

Compare Ridaura with other medications

• Felty's Syndrome
• Pemphigus
• Psoriatic Arthritis
• Rheumatoid Arthritis

Flunarizina Genfar

Flunarizina Genfar may be available in the countries listed below.

Ingredient matches for Flunarizina Genfar

Flunarizine

Flunarizine is reported as an ingredient of Flunarizina Genfar in the following countries:

• Colombia


• Peru

International Drug Name Search

Novoscabin

Novoscabin may be available in the countries listed below.

Ingredient matches for Novoscabin

Benzyl Benzoate

Benzyl Benzoate is reported as an ingredient of Novoscabin in the following countries:

• Poland

International Drug Name Search

Diméfline

Diméfline may be available in the countries listed below.

Ingredient matches for Diméfline

Dimefline

Diméfline (DCF) is also known as Dimefline (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Zelitrex

Zelitrex may be available in the countries listed below.

Ingredient matches for Zelitrex

Valacyclovir

Valaciclovir is reported as an ingredient of Zelitrex in the following countries:

• Luxembourg


• South Africa


• Tunisia

Valaciclovir hydrochloride (a derivative of Valaciclovir) is reported as an ingredient of Zelitrex in the following countries:

• Belgium


• Denmark


• France


• Italy


• Netherlands

International Drug Name Search